ArticleNanomaterials (Basel, Switzerland)2026
Elemental Boron Nanoparticles for Boron-Neutron Capture Therapy of BT-474 Human Breast Cancer.
Evgenii L Zavjalov, Linga D Romanenko, Olga I Kichakova, Anna I Kasatova, Polina A Kotelnikova, Dmitry S Petrunya, Ekaterina V Barmina, Kuder O Aiyyzhy, Artem A Laktionov, Sergei M Klimentov and 10 more
Abstract read
In one paragraphArticle in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
20 authors.
Evgenii L ZavjalovInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Linga D RomanenkoInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Olga I KichakovaInstitute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.ORCID 0000-0002-8218-2690 Anna I KasatovaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0002-6641-9344 Polina A KotelnikovaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0001-6570-8147 Dmitry S PetrunyaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0009-0004-9075-5622 Ekaterina V BarminaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0003-0735-2896 Kuder O AiyyzhyProkhorov General Physics Institute, Russian Academy of Sciences, Moscow 119991, Russia.
Artem A LaktionovInstitute of Engineering Physics of Biomedicine, National Research Nuclear University "MEPhI", Moscow 115409, Russia.ORCID 0009-0009-8140-6988 Sergei M KlimentovP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.
Anton A PopovInstitute of Engineering Physics of Biomedicine, National Research Nuclear University "MEPhI", Moscow 115409, Russia.ORCID 0000-0001-8902-0371 Maria S GrigoryevaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0000-0003-3759-5186 Timofey A BykovBudker Institute of Nuclear Physics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
Vasilisa V PodolyakoShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.
Anastasia A FronyaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.
Egor I MavreshkoP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.ORCID 0009-0007-8357-3531 Danila A PokhorukovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.ORCID 0009-0009-5684-0977 Sergey Yu TaskaevBudker Institute of Nuclear Physics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.ORCID 0000-0002-5313-2563 Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117437, Russia.ORCID 0000-0002-3952-0631 Irina N ZavestovskayaP.N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119333, Russia.
Funding
Russian Science Foundation 24-62-00018
6 · The paper itselfAbstract
Breast cancer remains one of the most common malignancies worldwide. Highly invasive HER2-positive breast cancer carries a high risk of metastasis and poses a significant therapeutic challenge. Boron neutron capture therapy (BNCT) may be an option for patients with this severe diagnosis. Here we evaluated the effectiveness of BNCT with elemental boron nanoparticles obtained by laser fragmentation and coated Silane-PEG-COOH and conjugated with the Affibody
Indexed as
Affibodyboron neutron capture therapy (BNCT)breast cancerBT-474elemental boron particles (BPs)HER2in vitroin vivomiceSCIDxenografts
Identifiers
PMID42646383
PMCPMC13515628
What OpenQuestion holds
Textmetadata
Read underepoch 390